The role of granulocyte colony-stimulating factors in the prevention of neutropenia and febrile neutropenia – the current state of knowledge
Journal Title: OncoReview - Year 2017, Vol 7, Issue 1
Abstract
Granulocyte colony-stimulating factors, introduced in the 1990s to prevent neutropenic fever, improve patients’ prognosis after myelotoxic chemotherapy. G-CSFs accelerate bone marrow recovery, shortening the duration of neutropenia and reducing its intensity as well as the risk of febrile neutropenia. There are short- and long-acting G-CSFs available these days. This paper is a review of the efficacy, toxicity and indications for short- and long-acting G-CSFs as indicated in the most recent studies.
Authors and Affiliations
Marta A. Sobas, Tomasz Wróbel
Keywords
Related Articles
- EP ID EP187335
- DOI -
- Views 207
- Downloads 0
Pericardiocentesis and pericardial therapy aspects in cancer patients - a case report
The malignancy related pericardial effusion has variable dynamics, and the clinical presentation and severity of symptoms are directly related to the degree of hemodynamic conditions and the rate of fluid accumulation in...
Depression in patients with cancer. Diagnosis and treatment in clinical practice
Comorbidity between depression and cancer is a common condition. It depends on many variables such as cancer location or phase of the illness, but as a rule this situation should not be neglected. The reasons for providi...
Adjuvant imatinib after resection of gastrointestinal stromal tumour – systematic review and meta-analysis
[b]Background[/b]: Adjuvant therapy is recommended for the population of patients with high risk of recurrence of gastrointestinal stromal tumour after resection.[b]The aim of the study[/b]: Evaluation of the clinical ef...
Original vs generic drugs in treatment of chronic myeloid leukaemia
The beginning of the twenty-first century saw a breakthrough in haematology, oncology and general medicine driven by the introduction of imatinib (Glivec) to the treatment of chronic myeloid leukaemia. For the first time...
Meeting the human. What can I get out of it?
Recently patients representatives are more often invited to oncological congresses. They would like to draw attention of the medical society to other than medical problems of people with cancer. Doctors should remember h...